These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 18350294

  • 1. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N, Basinko A, Morel F, Le Bris MJ, Ugo V, Morice P, Berthou C, De Braekeleer M.
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
    Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, Champion KM, Li J, Whittaker P, Stavrides G, Hunt AR, Huntly BJ, Campbell LJ, Bentley DR, Deloukas P, Green AR.
    Oncogene; 2000 Aug 10; 19(34):3902-13. PubMed ID: 10952764
    [Abstract] [Full Text] [Related]

  • 4. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K, Czepulkowski B, Sivalingam R, Hayes JP, Aldouri M, Sekhar M, Cummins M, Ho A, Mufti GJ.
    Cancer Genet Cytogenet; 2005 Jan 15; 156(2):154-7. PubMed ID: 15642396
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J, Zemanová Z, Ransdorfová S, Sindelárová L, Sisková M, Neuwirtová R, Cermák J, Michalová K.
    Cancer Genet Cytogenet; 2005 Jul 15; 160(2):188-92. PubMed ID: 15993278
    [Abstract] [Full Text] [Related]

  • 6. Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies.
    Okada M, Suto Y, Hirai M, Shiseki M, Usami A, Okajima K, Teramura M, Mori N, Motoji T.
    Cancer Genet; 2012 Jul 15; 205(1-2):18-24. PubMed ID: 22429594
    [Abstract] [Full Text] [Related]

  • 7. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C.
    Ann Hematol; 2009 Dec 15; 88(12):1207-13. PubMed ID: 19415278
    [Abstract] [Full Text] [Related]

  • 8. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR, Oh B, Hong DS, Zang DY, Yoon HJ, Kim HJ, Kim I, Ahn JS, Cheong JW, Lee KA, Cho KS, Lee MH, Bang SM, Kim TY, Yun YM, Min YH, Lee YK, Lee DS, AML/MDS Working Party of the Korean Society of Hematology.
    Cancer Genet Cytogenet; 2010 Dec 15; 203(2):193-202. PubMed ID: 21156233
    [Abstract] [Full Text] [Related]

  • 9. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
    Siew-Gek Lee A, Rudduck-Sivaswaren C, Khun-Hong Lie D, Li-Ming Chua C, Tien SL, Morsberger L, Griffin CA.
    Cancer Genet Cytogenet; 2004 Sep 15; 153(2):151-7. PubMed ID: 15350305
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
    Zhang LJ, Shin ES, Yu ZX, Li SB.
    Chin Med J (Engl); 2007 Nov 20; 120(22):2002-5. PubMed ID: 18067786
    [Abstract] [Full Text] [Related]

  • 11. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.
    Douet-Guilbert N, Laï JL, Basinko A, Gueganic N, Andrieux J, Pollet B, Plantier I, Delattre C, Crépin O, Corm S, Le Bris MJ, Morel F, De Braekeleer M.
    Br J Haematol; 2008 Dec 20; 143(5):716-20. PubMed ID: 19036015
    [Abstract] [Full Text] [Related]

  • 12. A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies.
    MacKinnon RN, Campbell LJ.
    Cancer Genet Cytogenet; 2005 Dec 20; 163(2):176-9. PubMed ID: 16337864
    [Abstract] [Full Text] [Related]

  • 13. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J, Zemanová Z, Ransdorfová S, Pavlistová L, Babická L, Housková L, Melichercíková J, Sisková M, Cermák J, Michalová K.
    Cancer Genet Cytogenet; 2007 Feb 20; 173(1):10-6. PubMed ID: 17284364
    [Abstract] [Full Text] [Related]

  • 14. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
    Wang PW, Iannantuoni K, Davis EM, Espinosa R, Stoffel M, Le Beau MM.
    Genes Chromosomes Cancer; 1998 Feb 20; 21(2):75-81. PubMed ID: 9491317
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O.
    Verh Dtsch Ges Pathol; 2007 Feb 20; 91():140-53. PubMed ID: 18314608
    [Abstract] [Full Text] [Related]

  • 17. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V, Cozza A, Berkofsy-Fessler W, Prchal J, Scalise A.
    Exp Hematol; 2007 Nov 20; 35(11):1668-76. PubMed ID: 17976519
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY, Xue YQ, Wu YF, Pan JL, Liu DD, Gong SL.
    Zhonghua Yi Xue Za Zhi; 2004 May 02; 84(9):732-5. PubMed ID: 15200909
    [Abstract] [Full Text] [Related]

  • 20. The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion.
    Mackinnon RN, Selan C, Wall M, Baker E, Nandurkar H, Campbell LJ.
    Genes Chromosomes Cancer; 2010 Nov 02; 49(11):998-1013. PubMed ID: 20645416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.